Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction: Thalassemia is an inherited blood disorder characterized by defective hemoglobin production, leading to chronic anemia. Patients, particularly those who are transfusion-dependent, face a heightened risk of infections due to disease-related factors like anemia and treatment-related complications such as iron overload and splenectomy. This study explores the factors contributing to infections in thalassemia patients to improve management strategies. Methods: A retrospective analysis was conducted on 303 patients with thalassemia at a tertiary care center from 2007 to 2022. Data were collected on demographics, transfusion dependency, splenectomy status, ferritin levels, vaccination history, and culture results. Logistic regression analysis was used to identify infection risk factors, with significance set at p < 0.05. Results: Out of 303 patients, 72 (23.8%) experienced culture-positive infections, with Escherichia coli being the most isolated pathogen. Patients with infections had significantly higher ferritin levels and were less likely to be on chelation therapy. Combined chelation therapy, however, showed a protective effect (OR: 0.02, p = 0.01). Female patients were more susceptible to infections (OR: 2.94, p = 0.04), while mortality was notably higher in patients with positive cultures (22% vs. 3%, p < 0.001). Conclusion: This study highlights the strong link between iron overload, chelation and risk of infection in thalassemia patients. Effective management, including proper chelation therapy and monitoring ferritin levels, is critical for reducing infections and improving outcomes. Further studies are needed to confirm these findings and guide future management strategies.
Authors: EMAN MANSORY, Lina Abdulrahman, Balsam Osman, Sawsan Sawsan, Assil Ruckn, Marwa Aljedaani, Nemmat Hassan, Ahmed Barefah, Hatem Alahwal, Yassir Daghistani, Salem Bahashwan, Abdullah Almohammadi, Osman Radhwi
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $647
OpenAlex ID: W4413857334
